Association of inhaled corticosteroid use with cataract extraction in elderly patients

JAMA

Volumn 280, Issue 6, 1998, Pages 539-543

  Garbe, Edeltraut ^a   Suissa, Samy ^a   Lelorier, Jacques ^a  

^a Potsdam Institute for Pharmacoepidemiology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE; BUDESONIDE; CORTICOSTEROID; CORTISONE; DEXAMETHASONE; FLUNISOLIDE; HYDROCORTISONE; METHYLPREDNISOLONE; PREDNISOLONE; PREDNISONE; TRIAMCINOLONE;

AGED; ARTICLE; CANADA; CATARACT; CATARACT EXTRACTION; CATARACTOGENESIS; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; DRUG MEGADOSE; FEMALE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTRAOCULAR DRUG ADMINISTRATION; LONG TERM EXPOSURE; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PHARMACOEPIDEMIOLOGY; PRIORITY JOURNAL; RISK FACTOR;

EID: 0032511375     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.280.6.539     Document Type: Article

References (44)

1. Reed CE. Aerosol glucocorticoid treatment of asthma. Am Rev liespir Dis. 1990;141(suppl):S82-S88.
2. British Thoracic Society. Guidelines for management of asthma in adults, I: chronic persistent asthma. BMJ. 1990;301:G51-G53.
3. British Thoracic Society. Guidelines for the management of asthma: a summary. BMJ. 1993;306:776-782.
4. Barnes PJ. Inhaled glucocorticoids for asthma. NEnglJMed. 1995;332:868-875.
5. Barnes NC. Safety of high-dose inhaled corticosteroids. RespirMed. 1993;87(suppl):27-31.
6. Black RL, Oglesby RB, von Sallmann L, Bunim JJ. Posterior subcapsular cataracts induced by corticosteroids in patients with rheumatoid arthritis. JAMA. 1960;174:166-171.
7. Urban RC Jr, Collier E. Corticosteroid-induced cataracts. Surv Ophthalmol. 1986;31:102-110.
8. Renfro L, Snow JS. Ocular effects of topical and systemic steroids. Dermatol Clin. 1992;10:505-512.
9. Allen MB, Ray SG, Leitch AG, Dhillon B, Cullen B. Steroid aerosols and cataract formation. BMJ. 1989;299:432-433.
10. Karim AKA, Thompson GM, Jacob TJC. Steroid aerosols and cataract formation. BMJ. 1989;299:918.
11. Kewley GD. Possible association between beclomethasone diproprionate aerosol and cataracts. Aust Paediatr J. 1980;16:117-118.
12. Fraunfelder FT, Meyer SM. Posterior subcap-sular cataracts associated with nasal or inhalation corticosteroids. Am J Ophthalmol. 1990;109:489-490.
13. Abuekteish F, Kirkpatrick JNP, Russell G. Posterior subcapsular cataract and inhaled corticosteroid therapy. Thorax. 1995;50:674-676.
14. Simons FER, Persaud IIP, Gillespie CA, Cheang II, Shuckett EP. Absence of posterior subcapsular cataracts in young patients treated with inhaled glucocorticoids. Lancet. 1993;342:776-778.
15. Tinkelman DG, Reed CE, Nelson HS, Offord KP. Aerosol beelomethasone dipropionate compared with theophylline as primary treatment of chronic, mild to moderately severe asthma in children. Pediatrics. 1993;92:64-77.
16. Toogood JH, Markov AE, Baskerville J, Dyson C. Association of ocular cataracts with inhaled and oral steroid therapy during long-term treatment of asthma. J Allergy Clin Immitnol. 1993;91:571-579.
17. Nassif E, Weinberger M, Sherman B, Brown K. Extrapulmonary effects of maintenance corticosteroid therapy with alternate-day prednisone and inhaled beelomethasone in children with chronic asthma. J Allergy Clin Immuiiol. 1987;80:518-529.
18. Cumming RG, Mitchell P, Leeder SR. Use of inhaled corticosteroids and the risk of cataracts. N Engl J Med. 1997;337:8-14.
19. Cumming RG, Mitchell P, Leeder SR. Inhaled corticosteroids and the risk of cataract. N Engl J Med. 1997;337:1555.
20. Garbe E, Suissa S. Inhaled corticosteroids and the risk of cataracts. N Engl J Med. 1997;337:1555.
21. Tamblyn R, Lavoie G, Petrella L, Monette J. The use of prescription claims databases in pharmacoepidemiological research: the accuracy and comprehensiveness of the prescription claims database in Quebec. J Clin Epidemiol. 1995;48:999-1009.
22. World Health Organization. International Classification of Diseases, Ninth Revision (ICD-9). Geneva, Switzerland: World Health Organization; 1977.
23. SAS Institute Inc. The PHREG procedure. In: SAS Technical Report P-299: SAS/STAT Software: Changes and Enhancements, Release 6.07. Gary, NC: SAS Institute Inc; 1992:435-479.
24. Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic Research. New York, NY: Van Nostrand Reinhold Co; 1982.
25. Hodge WG, Whitcher JP, Satariano W. Riskfactors forage-related cataracts. Epidemiol Rev. 1995;17:336-346.
26. Livingston PM, Carson CA, Taylor HR. The epidemiology of cataract: a review of the literature. Ophthalmic Epidemiol. 1995;2:151-164.
27. Leske MC, Sperduto RD. The epidemiology of senile cataracts: a review. Am J Epidemiol. 1983;118:152-165.
28. West SK, Valmadrid CT. Epidemiology of risk factors for age-related cataract. Surv Ophthalmol. 1995;39:323-334.
29. Klein BEK, Klein R, Jensen SC, Linton KLP. Hypertension and lens opacities from the Beaver Dam Eye Study. Am J Ophthalmol. 1995;119:640-646.
30. Bonomi L. Cataracts induced by topical ocular medications. Dev Ophthalmol. 19S9;17:196-198.
31. Harding JJ, Egerton M, van Heyningen R, Hording RS. Diabetes, glaucoma, sex, and cataract: analysis of combined data from two case-control studies. Br J Ophthalmol. 1993;77:2-6.
32. van Heyningen R, Harding JJ. Do aspirin-like analgesics protect against cataract? a case-control study. Lancet. 1986;1:1111-1113.
33. Isaac NE, Walker AM, Jick H, German M. Exposure to phenothiazine drags and risk of cataract. Arch Ophthalmol. 1991;109:256-260.
34. Bochow TW, West SK, Azar A, Munoz B, Sommer A, Taylor HR. Ultraviolet light exposure and risk of posterior subcapsular cataracts. Arch Ophthalmol. 1989;107:369-372.
35. Jick H, Brandt DE. Allopurinol and cataracts. Am J Ophthalmol. 1984;98:355-358.
36. Walker AM, Jick H, Gorman MR, Wallach RW. Steroids, diabetes, analgesics, and the risk of cataract: lessons from the epidemiology of cataract extraction. J Clin Res Dnig Dev. 1988;2:227-232.
37. Harding JJ, van Heyningen R. Drags, including alcohol, that act as risk factors for cataract, and possible protection against cataract by aspirin-like analgesics and cyclopenthiazide. Br J Ophthalmol. 1988;72:809-814.
38. Dolezal JM, Perkins ES, Wallace RB. Sunlight, skin sensitivity, and senile cataract. Am J Epidemiol 1989;129:559-568.
39. Munoz B, Tajchman U, Bochow T, West S. Alcohol use and risk of posterior subcapsular opacities. Arch Ophthalmol 1993;111:110-112.
40. The Italian-American Cataract Study Group. Risk factors for age-related cortical, nuclear, and posterior subcapsular cataracts. Am J Epidemiol. 1991;133:541-553.
41. Mohan SI, Sperduto RD, Angra SK, et al. IndiaUS case-control study of age-related cataracts. Arch Ophthalmol. 1989;107:670-676.
42. Troisi RJ, Speizer FE, Rosner B, Trichopoulos D, Willett WC. Cigarette smoking and incidence of chronic bronchitis and asthma in women. Chest. 1995;108:1557-1561.
43. Forero R, Bauman A, Young L, Larkin P. Asthma prevalence and management in Australian adolescents: results from three community surveys. J Adolesc Health. 1992;13:707-712.
44. Hanania NA, Chapman KR, Kesten S. Adverse effects of inhaled corticosteroids. Am J Med. 1995; 98:190-208.